Northwest Bank & Trust’s Pfizer PFE Stock Holding History

Northwest Bank & Trust’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	$472K	Sell	18,033 -50	-0.3%	-$1.36K	0.35%	66
2024 Q3	$523K	Sell	18,083 -30	-0.2%	-$875	0.4%	61
2024 Q2	$507K	Sell	18,113 -1,536	-8%	-$42.3K	0.42%	62
2024 Q1	$503K	Sell	19,649 -911	-4%	-$25.3K	0.46%	62
2023 Q4	$592K	Buy	+20,560	New	+$622K	0.53%	60
2023 Q2	$789K	Buy	+21,515	New	+$837K	0.76%	39

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Northwest Bank & Trust's PFE Position: Q4 2024 in Review

Northwest Bank & Trust reduced its Pfizer (PFE) stake by 0.28% in Q4 2024, selling an estimated $1.36K and leaving 18,033 shares worth $472K. The position accounts for 0.35% of the portfolio, ranked #66.

Northwest Bank & Trust first reported a position in PFE in Q2 2023 and has held it in 6 quarters since. The position peaked at $789K in Q2 2023. 3,001 funds tracked by Wall St. Rank hold PFE as of Q4 2024.

Northwest Bank & Trust held 18,033 shares of Pfizer worth $472K as of Q4 2024.
Northwest Bank & Trust sold 50 Pfizer shares in Q4 2024, an estimated $1.36K.
Pfizer made up 0.35% of Northwest Bank & Trust's portfolio in Q4 2024, its #66 holding.
Northwest Bank & Trust first reported a position in Pfizer in Q2 2023 and has held it in 6 quarters since.
Northwest Bank & Trust's Pfizer position peaked at $789K in Q2 2023.
3,001 funds tracked by Wall St. Rank held Pfizer as of Q4 2024.

Based on Northwest Bank & Trust's 13F filing for Q4 2024, filed 18 Feb 2025.